A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization

Site reference no. 93598, Brussels

Site reference no. 113176, Vienna

Site reference no. 93615, Brussels

Site reference no. 93617, Brussels

Site reference no. 93593, Brasschaat

Site reference no. 93595, Leuven

Site reference no. 93616, Hasselt

Site reference no. 93613, Genk

Site reference no. 93614, Mons

Site reference no. 93594, Ghent

Site reference no. 93597, Ghent

Site reference ID ORG-000645, Berlin

Site reference ID ORG-000643, Berlin

Site reference no. ORG-000633, Turku

Site reference ID ORG-000883, Lübeck

Site reference no. ORG-000640, Pozuelo de Alarcon (Madrid)

Site reference ID ORG-000795, Tampere

Research facility ID ORG-000934, Hadera

Site reference ID ORG-000885, Jyväskylä

Site reference no. ORG-000638, Seville

Site reference no. ORG-000637, Valencia

Site reference no. 119915, Baracaldo, Vizcaya

Site reference no. ORG-000639, Bilbao

Site reference ID ORG-000644, Heidelberg

Site reference no. 93641, Tel Aviv

Site reference no. 93635, Beersheba

Site reference no. ORG-000635, Oulu

Site reference no. 93638, Jerusalem

FGBU Endocrinology Research Center of Minzdrav of Russia, Moscow

Moscow State Medical Dentistry University, Moscow

"CJSC Nasledniki", Moscow

Moscow State Medical Dentistry University, Moscow

SBEIHPE - NWSMU n.a.l.l.Melnichko MoH and SD of RF, Saint Petersburg

"St. Petersburg SBHI Maternity Hospital No 17 (main address)", Saint Petersburg

"FSBI Ural SRI of Maternity and Child Protection of MoH and SD", Yekaterinburg

Center of Family Medicine LC, Yekaterinburg

Research facility ID ORG-000935, Haifa

Site reference ID ORG-000884, Helsinki

Site reference ID ORG-000642, Dresden

Site reference ID ORG-000791, Barcelona